Search
Now showing items 1-4 of 4
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and-experienced injection drug users and non-drug users
(BioMed Central, 2015-08-15)
Background Although injection drug use drives antiretroviral drug resistance, the prevalence
of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We,
therefore, explored PI resistance mutations ...
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and-experienced injection drug users and non-drug users
(BioMed Central, 2015-08-11)
Background Although injection drug use drives antiretroviral drug resistance, the prevalence
of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We,
therefore, explored PI resistance mutations ...
Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya
(BioMed Central, 2015-07-30)
Background Information about HBV sero-markers, infection stages and genotypes in HIV-1
infected and uninfected injection and non-injection drug users (IDUs) in Kenya remains
elusive. Methods A cross-sectional study ...
Clinical chemistry profiles in injection heroin users from Coastal Region, Kenya
(Biomed central, 2014-07-09)
Background Although the co-burden of injection drug use and HIV is increasing in Africa,
little is known about the laboratory markers of injection drug use and anti-retroviral treatment
(ART) in Kenyan injection drug ...